| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 62 |
| 1 | RITUXIMAB | 23 |
| 2 | OFATUMUMAB | 21 |
| 3 | ERGOCALCIFEROL | 15 |
| 4 | MYCOPHENOLATE MOFETIL | 15 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 15 |
| 6 | ACETAMINOPHEN | 14 |
| 7 | PREDNISONE | 14 |
| 8 | METHYLPREDNISOLONE | 13 |
| 9 | ACETAMINOPHEN 500MG | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DYCLONINE HYDROCHLORIDE | 1 | 0.0105 |
| 1 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 2 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| 3 | OCRELIZUMAB | 62 | 0.0010 |
| 4 | CHLORAMBUCIL | 3 | 0.0008 |
| 5 | OFATUMUMAB | 21 | 0.0006 |
| 6 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 7 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 8 | ERGOCALCIFEROL | 15 | 0.0005 |
| 9 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 1 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 104 | 0.0003 |
| 4 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 5 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 7 | Vitamin K [EPC] | 1 | 0.0001 |
| 8 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |